Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing- Remitting Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|4|647-651

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.4, 2014-06, pp. : 647-651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis

By Simpson D.   Noble S.   Perry C.  

CNS Drugs, Vol. 16, Iss. 12, 2002-01 ,pp. : 825-850

Adis International

Access to resources Recommend Favorite

Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains

By Iritani S.   Niizato K.   Nawa H.   Ikeda K.   Emson P.C.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 801-807

Elsevier

Access to resources Recommend Favorite

A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors

By Malcangio M.   Lessmann V.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 3, 2003-03 ,pp. : 116-121

Elsevier

Access to resources Recommend Favorite

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis

By Carter Natalie J.   Keating Gillian M.  

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1545-1577

Adis International

Access to resources Recommend Favorite

Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets

By  

Current Neuropharmacology, Vol. 14, Iss. 7, 2016-08 ,pp. : 721-731

Bentham Science Publishers

Access to resources Recommend Favorite